Search

Contributor:

Andrew M. Schimel, MD

Severe Diabetic Tractional Retinal Detachment With Recurrent Vitreous Hemorrhage

Severe Diabetic Tractional Retinal Detachment With Recurrent Vitreous Hemorrhage

Andrew Schimel, MD

Expert Panel: Surgical Complications

Expert Panel: Surgical Complications

Andrew Schimel, MD, Anton Orlin, MD

A New Scleral Depressor

A New Scleral Depressor

Andrew Schimel, MD, Bozho Todorich, MD, PhD

Complications and Controversies in Retinal Surgery

Complications and Controversies in Retinal Surgery

Andrew Schimel, MD

A Treatment Paradigm for Wet AMD

A Treatment Paradigm for Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 3 Clinical Trial Data for EYLEA HD<sup>®</sup> (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Phase 3 Clinical Trial Data for EYLEA HD^® (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 2/3 Clinical Trial Data for EYLEA HD<sup>®</sup> (aflibercept) Injection 8 mg for the Treatment of DME

Phase 2/3 Clinical Trial Data for EYLEA HD^® (aflibercept) Injection 8 mg for the Treatment of DME

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD